azacitidine,venetoclax
abbvie,roche
['venetoclax', 'mantle,(-dismantle)', 'azacitidine,(-oral azaci),(-azacitidine oral)', 'aza ', '+aza', 'leusm']
#ash22 #leusm d hner: genetics-based aza/ven efficacy model using only flt3-itd, kras, nras, and tp53 stratifies intro three separated groups with higher benefit (med os 26mos), intermed benefit (12mos) and lower benefit (5.5mos). 
Assoc Professor, UCSF hematology/BMT. Translational researcher interested in leukemia, MDS, MRD, post-HCT relapse, GVHD, & immune recon. Photos: pyknosis (IG)